Guest
Login
Sign Up
Site settings
Forgot Password?
Tadeusz Robak, MD of the Poznań University of Medical Sciences in Poland provides a summary of a phase II clinical trial assessing rozanolixizumab ...
Autoplay video
Hide player controls
Hide resume playing